Guggenheim raised the firm’s price target on Neogen (NEOG) to $12 from $8 and keeps a Buy rating on the shares after the company beat revenue and EBITDA expectations and raised guidance. While stating that one quarter “does not make a trend,” the firm adds that the portfolio performed well and cost actions “clearly are starting to take hold.”
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEOG:
- Neogen Earnings Call Marks Early Turnaround Momentum
- Midday Fly By: Defense stocks surge on Trump budget request
- Morning Movers: Neogen skyrockets following Q2 results and raised FY26 guidance
- Neogen raises FY26 revenue view to $845M-$855M from $820M-$840M
- Neogen reports Q2 adjusted EPS 10c, consensus 7c